As U.S. politicians turn to transparency as a fix-all for rising drug costs, research by Ginger Scanlon (PhD ’25) is a reminder that shining a light on the system can sometimes make things more tangled, not less. She studied how disclosure laws for pharmacy benefit managers (PBMs) affect drug pri...
